V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20045322 | 20086298 | null | null | null | 2016-11-07 | 2016-11-09 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | Y | HYDROXYCARBAMIDE | 100086324 |
| 20045341 | 20086299 | 1.62 | 89.6 | Palliative (P) | 2018-07-01 | 2018-07-22 | CAP + RT | N | N | BENDAMUSTINE + RITUXIMAB | 101505595 |
| 20045404 | 20086301 | 1.82 | 47 | Palliative (P) | 2019-07-23 | 2019-08-03 | Carbo F | 1 | N | CAPECITABINE + STREPTOZOCIN | 100853686 |
| 20045466 | 20086302 | 1.62 | 40.4 | Adjuvant (A) | null | 2016-11-03 | Rituximab | N | N | CAP + RT | 100860156 |
| 20045481 | 20086303 | 1.52 | 76 | 03 | 2018-06-28 | 2018-07-05 | null | N | null | HYDROXYCARBAMIDE | 100806535 |
| 20045544 | 20086304 | 1.54 | 72.5 | 03 | 2017-04-20 | 2017-04-24 | Raltitrexed | 02 | N | CISPLATIN + IFOSFAMIDE + MITOMYCIN | 101208315 |
| 20045570 | 20086305 | 1.83 | 65.8 | 03 | 2018-08-10 | 2018-08-24 | ARISTOTLE TRIAL | 02 | N | LENALIDOMIDE | 100821226 |
| 20045591 | 20086306 | 1.73 | 76 | 03 | 2016-02-03 | 2016-03-08 | EOF | 02 | N | ECARBOX | 100856370 |
| 20045603 | 20086307 | 1.81 | 105 | Palliative (P) | 2020-01-07 | 2020-01-21 | Irinotecan | 01 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 101623196 |
| 20045783 | 20086309 | null | null | Adjuvant (A) | 2018-05-29 | 2018-06-11 | NEO-AEGIS TRIAL | 02 | Y | ABIRATERONE | 100219901 |
| 20045943 | 20086311 | 1.61 | 81 | null | 2018-10-27 | 2018-11-04 | Tegafur | 02 | N | FOXFIRE TRIAL | 100370602 |
| 20045944 | 20086312 | 1.84 | 59.8 | 03 | 2019-07-24 | 2019-07-31 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | GEMCARBO | 101069951 |
| 20045968 | 20086313 | 1.59 | 103.2 | 03 | 2016-04-18 | 2016-10-17 | MITOMYCIN | 2 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101603231 |
| 20045974 | 20086314 | 1.74 | 112 | null | 2019-02-07 | 2019-02-27 | FCarboSt | null | N | PACLITAXEL | 100439227 |
| 20045990 | 20086315 | 1.74 | 76.2 | 03 | 2015-11-16 | 2015-12-01 | PHITT C Carboplatin/Doxorubicin | 02 | N | DOCETAXEL | 100801085 |
| 20045991 | 20086316 | 1.63 | 63 | 03 | 2020-01-19 | 2020-01-26 | PACLITAXEL | 01 | N | EOF | 101438792 |
| 20046060 | 20086319 | null | 62.3 | Palliative (P) | 2019-12-19 | 2019-12-22 | ECarboX | N | N | OXALIPLATIN | 101373762 |
| 20046090 | 20086320 | 1.75 | 56.8 | Palliative (P) | 2016-11-16 | 2016-12-12 | STAR TRIAL | N | N | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 101084363 |
| 20046120 | 20086321 | 1.56 | 62 | Palliative (P) | 2017-01-10 | 2017-01-17 | Rituximab | 99 | N | LENALIDOMIDE | 100154973 |
| 20046135 | 20086322 | 1.63 | 79.6 | Palliative (P) | 2018-07-18 | 2018-08-04 | Cisplatin+Fluorouracil+Streptozoc | 01 | N | DOXORUBICIN + OLARATUMAB | 100166988 |
| 20046165 | 20086323 | 1.55 | 66.4 | 03 | 2018-06-17 | 2018-06-21 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | ESPAC TRIAL | 100297936 |
| 20046166 | 20086324 | 1.63 | 52.6 | 03 | 2019-08-10 | 2019-08-24 | ACTICCA-1 Trial | 01 | N | CISPLATIN + RALTITREXED | 101497078 |
| 20046195 | 20086325 | 1.74 | 58.9 | Palliative (P) | 2018-12-12 | 2018-12-20 | Paclitaxel albumin (Abraxane) 21day | 02 | N | CVP R | 100573189 |
| 20046218 | 20086326 | 1.67 | 101 | null | 2016-10-10 | 2016-10-14 | CHLORAMBUCIL + RITUXIMAB | N | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100295046 |
| 20046265 | 20086327 | 1.57 | 71.45 | 03 | 2019-11-12 | 2019-11-13 | Bevacizumab + Cape + Oxali 21day | 02 | N | PACLITAXEL | 100570304 |
| 20046270 | 20086328 | 1.8 | 79 | Palliative (P) | null | 2018-11-24 | ESPAC-4 TRIAL | 01 | N | GEMCITABINE + PACLITAXEL | 100604351 |
| 20046305 | 20086329 | 1.83 | 103.1 | Palliative (P) | 2018-04-04 | 2018-04-29 | Topotecan (oral) | 02 | Y | ANAGRELIDE | 100067118 |
| 20046307 | 20086330 | 1.67 | null | Palliative (P) | 2019-10-04 | 2019-10-04 | PLATO Trials | 02 | N | PLATO TRIAL | 101081096 |
| 20046308 | 20086331 | 1.76 | 52.6 | null | 2017-11-30 | 2017-12-13 | null | 01 | Y | SUNITINIB | 100848452 |
| 20046435 | 20086332 | 1.7 | 60 | Palliative (P) | 2017-06-15 | 2017-06-15 | Hydroxycarbamide | N | N | CHLORAMBUCIL + RITUXIMAB | 100584686 |
| 20046507 | 20086333 | 1.65 | 53.5 | Palliative (P) | 2016-03-24 | 2016-05-07 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | INTERAACT TRIAL | 100083038 |
| 20046538 | 20086334 | 1.55 | 60.3 | 03 | 2018-11-28 | 2018-12-12 | FLAG + Idarubicin | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101222807 |
| 20046615 | 20086335 | 1.78 | 65 | Palliative (P) | null | 2016-07-10 | Cisplatin + Fluorouracil + RT 5day | 01 | N | MITOMYCIN | 100101513 |
| 20046683 | 20086336 | 1.68 | 79 | Palliative (P) | 2019-04-30 | 2019-05-16 | Hepatoblastoma SR Cisplatin | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100994905 |
| 20046744 | 20086337 | 1.68 | 78.1 | null | 2018-01-29 | 2018-02-25 | null | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101550936 |
| 20046775 | 20086338 | 1.79 | 69.5 | Palliative (P) | 2021-05-18 | 2021-05-28 | LENALIDOMIDE | 02 | N | CAPITAL TRIAL | 100649822 |
| 20046786 | 20086339 | 1.92 | 89 | Adjuvant (A) | 2016-06-24 | 2016-06-24 | FEC 100 | 02 | N | TAC | 100371344 |
| 20046804 | 20086340 | 1.73 | 62.3 | null | 2017-11-21 | 2017-11-24 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | ACTICCA-1 TRIAL | 100552484 |
| 20046856 | 20086341 | 1.59 | 63.5 | 03 | 2018-08-20 | 2018-08-27 | Fluorouracil + Streptozocin | 02 | N | ACELARATE TRIAL | 100638268 |
| 20046868 | 20086342 | 1.59 | 69.6 | Palliative (P) | 2018-12-16 | 2018-12-16 | Azacitidine | 01 | N | BENDAMUSTINE + OBINUTUZUMAB | 100852546 |
| 20046906 | 20086343 | 1.56 | 67.2 | 03 | 2019-01-14 | 2019-01-14 | HEP SIOPEL 3, PLADO | 02 | N | EVEROLIMUS | 101644480 |
| 20046921 | 20086344 | 1.57 | 58 | Palliative (P) | 2017-04-29 | 2017-04-29 | ACTICCA-1 Trial | N | null | GEMCITABINE + PACLITAXEL | 100205094 |
| 20046986 | 20086345 | 1.79 | 53.6 | 03 | 2019-12-21 | 2019-12-21 | CHOP - 21 days | 02 | null | HEP SIOPEL 6 CISPLATIN | 101323889 |
| 20046996 | 20086346 | null | 76.9 | null | 2019-02-01 | 2019-02-17 | Gemcitabine + Paclitaxel | 02 | N | EVEROLIMUS | 100346248 |
| 20047084 | 20086347 | 1.85 | 81.8 | Palliative (P) | 2016-02-23 | 2016-02-23 | IRINOTECAN + MDG + PANITUMUMAB | 01 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100649433 |
| 20047111 | 20086348 | 1.89 | 93 | 03 | 2019-01-06 | 2019-02-04 | EC | N | N | CEMIPLIMAB | 101809268 |
| 20047205 | 20086349 | 1.69 | 78.7 | Curative (C) | 2017-05-06 | 2017-05-06 | PEGINTERFERON ALFA | 02 | N | PACLITAXEL | 101704070 |
| 20047264 | 20086351 | 1.78 | 54.4 | Palliative (P) | 2019-02-27 | 2019-03-02 | PEMBROLIZUMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 100830185 |
| 20047267 | 20086352 | 1.65 | 56 | 03 | 2016-03-27 | 2016-04-16 | ESPAC-4 TRIAL | 01 | N | DOXORUBICIN | 100200283 |
| 20047294 | 20086353 | 1.85 | 84.9 | 03 | null | 2019-01-31 | NIVOLUMAB | 02 | N | CISPLATIN + FU + TRASTUZUMAB | 101148786 |